Is CNA a Buy or a Sell? The Bull and Bear Case (2026)

Last updated October 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for CNA Financial Corporation (CNA) rests on Commercial P&C pricing and underwriting discipline: CNA's core earnings depend on writing commercial and specialty coverage at profitable rates, reflected in a combined ratio that ran in the mid-90s through 2025. The bear case rests on cNA is exposed to catastrophe losses (hurricanes, wildfires, severe storms) that can spike the combined ratio in any given quarter, as well as the risk that prior-year reserves prove inadequate for long-tail casualty claims, a risk that showed up in 2026 through 4.1 points of adverse development in excess casualty and professional E&O in the first quarter and a $77 million after-tax legacy mass tort charge in the second. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

CNA Financial Corporation is an insurance holding company that writes commercial property and casualty coverage, including specialty lines, standard commercial insurance, and international business, largely for businesses rather than individuals. Its earnings come from two engines: underwriting profit (premiums collected versus claims and expenses, tracked through the combined ratio) and net investment income earned on a large bond-heavy portfolio. Loews Corporation owns roughly 90% of the shares, so CNA operates as the primary insurance subsidiary within that conglomerate. The investment picture is one of stability and income rather than rapid growth. CNA posted full-year 2025 net income of about $4.69 per share and a property and casualty combined ratio of roughly 94.7% (below 100% means underwriting profit), with mid-single-digit net written premium growth. The stock is known for a sizable dividend program that combines a regular quarterly payout with periodic special dividends, which pushes its headline yield well above most insurers. The main caveats are a very high parent ownership stake that limits float and public influence, and sensitivity to catastrophe losses, reserve adequacy, and interest rates. 2026 has been a softer underwriting year. The first quarter brought core income of $0.83 per share against a consensus near $1.24, with a P&C combined ratio of 102.2% that included 4.1 points of unfavorable prior-period reserve development in excess casualty and professional E&O lines. The second quarter recovered to core income of $1.19 per share, above the $1.05 estimate, but the P&C combined ratio was still 96.5% (94.2% underlying, up from 91.7% a year earlier) and Corporate and Other took a $77 million after-tax charge for legacy mass tort. Net written premiums grew 4% in the quarter and net investment income rose to $701 million. Book value per share was $41.34 at June 30, 2026 ($45.83 excluding AOCI). The shares are up about 2% in 2026 and 6% over twelve months, and third-quarter results are due November 2, 2026, with consensus core EPS near $1.13.

The bull case for CNA

1. Commercial P&C pricing and underwriting discipline

CNA's core earnings depend on writing commercial and specialty coverage at profitable rates, reflected in a combined ratio that ran in the mid-90s through 2025. In 2026 that margin has thinned: the P&C combined ratio was 102.2% in the first quarter (including adverse reserve development) and 96.5% in the second, while the underlying combined ratio rose to about 94% from roughly 92% a year earlier. Renewal premium change slowed to +2% to +3%, so pricing is no longer outrunning loss trends by much.

2. Net investment income

A large fixed-income portfolio generates investment income that is a major share of CNA's earnings. Higher reinvestment yields in recent years have lifted this line as older bonds roll into higher-coupon replacements. This income stream tends to be more stable than underwriting but moves with interest rates and credit spreads. Net investment income was $701 million in the second quarter of 2026, up from $610 million in the first, helped by a jump in limited-partnership and equity returns to $131 million while fixed income contributed $570 million.

3. Dividend program

CNA pays a regular quarterly dividend of $0.48 per share (about $1.92 a year, a yield near 4% at the October 2026 price) plus recurring special dividends; a $2.00 special was paid in 2026 alongside 2025 results, bringing dividends paid through June to $2.96 a share. Including that special, the trailing payout is roughly $3.92 a share, about an 8% yield. This combined payout drives an unusually high headline yield and is a central part of the total-return case. The specials are discretionary and vary year to year.

4. Loews ownership and capital return

With Loews owning roughly 90% of the shares, CNA is run as a cash-generating subsidiary and returns much of its excess capital through dividends. This alignment supports a shareholder-friendly payout but also means minority holders have limited sway over strategy and float is thin.

The bear case for CNA

CNA is exposed to catastrophe losses (hurricanes, wildfires, severe storms) that can spike the combined ratio in any given quarter, as well as the risk that prior-year reserves prove inadequate for long-tail casualty claims, a risk that showed up in 2026 through 4.1 points of adverse development in excess casualty and professional E&O in the first quarter and a $77 million after-tax legacy mass tort charge in the second. Its heavy fixed-income portfolio makes book value and investment income sensitive to interest-rate and credit-spread swings. The special dividends are discretionary and could shrink or disappear in a weaker year, which would hit the total-return thesis. The roughly 90% Loews ownership limits public float and minority-holder influence, and any conflict between parent and minority interests is a structural consideration. Broad commercial-insurance pricing cycles turning softer would pressure premium growth and margins. Analyst consensus expects 2026 core EPS of about $4.20, down roughly 15% from 2025, before a rebound to about $4.80 in 2027.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding CNA already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on CNA

Too few analysts publish on CNA for a consensus target to mean anything, so there is no professional average to weigh against your own view. That cuts both ways: less informed opinion to lean on, and less of it already priced in. The CNA forecast page covers what coverage does exist.

How is CNA valued? (as of October 2026)

Price

$47.90

Market cap

$12.96B

P/E (TTM)

10.67

Forward P/E

9.98

Price / book

1.16

Beta

0.27

52-week range

$41.53 to $55.71

Snapshot for CNA as of October 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

Market cap: ~$13B
Revenue (TTM): ~$15.2B
Net income (TTM): ~$1.24B (~$4.49/sh)
P&C combined ratio (Q2 2026): ~96.5% (underlying ~94.2%)
P/E (trailing / forward): ~10.7x / ~10x
Book value per share (Jun 30, 2026): ~$41.34 (~$45.83 ex-AOCI); ~1.16x book
Dividend yield: ~4% regular; ~8% including the $2.00 special

At about $47.87 on October 16, 2026, CNA trades near 10.7x trailing earnings and roughly 1.16x book value, a modest multiple for a mature commercial insurer whose 2026 underwriting margins have slipped. Consensus calls for core EPS near $4.20 in 2026 and $4.80 in 2027, with third-quarter results due November 2. The eye-catching yield reflects both the regular quarterly dividend and recurring special dividends rather than a distressed valuation, and roughly 90% Loews ownership means the small public float can amplify price moves.

How do you decide if CNA is a buy?

Rather than asking whether CNA is a buy in the abstract, it tends to help to answer four questions:

Thesis: do you believe the bull case above, and is it still true today?
Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
Overlap: check whether you already hold CNA indirectly through an index or sector ETF before adding more.

What would change your mind on CNA

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

Bull case breaks if: Commercial P&C pricing and underwriting discipline stalls in the reported numbers rather than in the narrative around them.
Bear case breaks if: cNA is exposed to catastrophe losses (hurricanes, wildfires, severe storms) that can spike the combined ratio in any given quarter, as well as the risk that prior-year reserves prove inadequate for long-tail casualty claims, a risk that showed up in 2026 through 4.1 points of adverse development in excess casualty and professional E&O in the first quarter and a $77 million after-tax legacy mass tort charge in the second fails to materialise over several reporting periods while the drivers keep compounding.
Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the CNA stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about CNA against your real portfolio and see your actual exposure before deciding.

Investing in CNA Financial Corporation with AI

Connect the broker you already use and ask Walnut's AI how CNA fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

Does CNA fit me?

FAQ

Is CNA a good stock to buy right now?

That depends on which case you find more convincing, and both are on this page. The bull case rests on Commercial P&C pricing and underwriting discipline, with revenue (ttm) at ~$15.2B. The bear case rests on cNA is exposed to catastrophe losses (hurricanes, wildfires, severe storms) that can spike the combined ratio in any given quarter, as well as the risk that prior-year reserves prove inadequate for long-tail casualty claims, a risk that showed up in 2026 through 4.1 points of adverse development in excess casualty and professional E&O in the first quarter and a $77 million after-tax legacy mass tort charge in the second. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Should I sell CNA?

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. CNA is exposed to catastrophe losses (hurricanes, wildfires, severe storms) that can spike the combined ratio in any given quarter, as well as the risk that prior-year reserves prove inadequate for long-tail casualty claims, a risk that showed up in 2026 through 4.1 points of adverse development in excess casualty and professional E&O in the first quarter and a $77 million after-tax legacy mass tort charge in the second. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. Walnut is not an investment adviser.

What is the bull case for CNA?

Commercial P&C pricing and underwriting discipline. CNA's core earnings depend on writing commercial and specialty coverage at profitable rates, reflected in a combined ratio that ran in the mid-90s through 2025.

What is the bear case for CNA?

What does CNA Financial Corporation do?

CNA Financial Corporation is an insurance holding company that writes commercial property and casualty coverage, including specialty lines, standard commercial insurance, and inter

What would have to change for CNA to stop being worth holding?

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Commercial P&C pricing and underwriting discipline) stalling in the reported numbers rather than in the narrative, the risk above (cNA is exposed to catastrophe losses (hurricanes, wildfires, severe storms) that can spike the combined ratio in any given quarter, as well as the risk that prior-year reserves prove inadequate for long-tail casualty claims, a risk that showed up in 2026 through 4.1 points of adverse development in excess casualty and professional E&O in the first quarter and a $77 million after-tax legacy mass tort charge in the second) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What does CNA Financial do?

CNA is a commercial property and casualty insurance holding company. It writes specialty lines, standard commercial coverage, and international business for companies, earning money from underwriting profit and from investment income on its bond portfolio.

Who owns CNA Financial?

Loews Corporation owns roughly 90% of CNA's shares, so CNA operates as Loews's primary insurance subsidiary. That leaves a relatively small public float and limited minority-shareholder influence over strategy.

Why is CNA's dividend yield so high?

CNA pays a regular quarterly dividend of $0.48 per share plus recurring special dividends, such as the $2.00 special paid in 2026 with its 2025 results. At about $47.87 in mid-October 2026, the regular dividend alone yields about 4%, and including the special the trailing yield is roughly 8%, well above most peers. The specials are discretionary.

Walnut is informational, not investment advice, and gives no verdict on CNA. Analyst targets referenced here come from a October 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.